BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

SYGNIS Pharma AG Says Stroke Drug AX200 Failed to Meet Study Goal


12/16/2011 7:56:14 AM

Sygnis Pharma AG’s experimental AX200 protein-based treatment for strokes failed to meet the primary goal of a mid-stage study, after a trial of the medication showed no difference for people treated with placebo. “The study recorded no clinical improvement and did not show any statistically significant difference,” the company said in a statement today. “Sygnis Pharma will continue to analyze the current data set and the new data that will become available in the weeks ahead.” The trial was based on 328 patients in Europe, the company said. The drug is the Heidelberg, Germany-based biotechnology company’s only product in development. Sygnis decided in October 2010 to cut its workforce in half as it adopted a strategy focused on getting AX200 to market.

Read at BusinessWeek
Read at Nasdaq

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES